Only spivs and chancers who came in after the crl care about 10p . As a long term holder who has a paper loss over £200k I want to get back to 40p...the pr coming out of the company is non existent, as a basic starting point we categorically should be told if the pack is in and a date has been set for the fda meeting
Ivy If they only have 8 salaried staff , why would they suggest that there was even a remote possibility that fhet couldn’t get through to fda meeting without raising funds. Trials are finished, surely it’s not possible to burn through $2m in a few months with current overheads being staff and external advisors?! Also do you think if things had gone the way we all expected and approval was granted, that they had agreements partnerships ready to announce to the market , or looking back now do you think they were struggling to get the right partnership in place?
In the last couple of weeks but I would love to know what, if any partnership/commercialisation/takeover agreements motif had lined up if we had been approved as expected.
normally when companies raise at a discount the sp invariably falls to that discounted price fairly quickly. I think with motif it may work in the reverse, and whatever price we may raise at it may lead to a significant increase in sp as it guarantees the company is still very much in the game, and can remain solvent in the short and medium term to hopefully get to approval. At the moment the market is uncertain how long we can keep the lights on for and when that is resolved it could be a catalyst for a rerate to mid-high teens.
this last week or 2 has been beyond confusing, disappointing and frankly non sensical. my main fear now is there has been some dark arts at play here and maybe someone has had a long term plan to bring motif down by hook or by crook and then Phoenix Iclaprim into another entity, have it for themselves and get approval...and make no mistake at some point Iclaprim will be approved . I genuinely think at something me point we may have to start a shareholders action group (shag) ironic since we’ve been royally f***ed !
Ian.B good to see you’re still alive and kicking too !
I’m abroad at the moment and quite frankly still in shock . I appreciate your posts in recent days and to some extent my faith has been restored that eventually this will be sorted and the long term holders who believed in the company and the science will get their money back... the board is mostly unreadable at present so I go straight to read your posts, so please keep posting. Many thanks
If there was a serious toxicity issue we clearly wouldn’t have passed phase 3 trials . That much has to be clear as day
Must say I agree with the point that we shouldn’t have to rerun phase 3 again, as it’s universally acknowledged that we passed with flying colours. Surely (hopefully) this is something more technical within our application, that we can redo and get the revised application fast tracked again.
My mrs is not talking to me, don’t really blame her. And we’re going to Dubai in about 3 hrs ! I need to perk up for the kids . Still in a state of shock
Sheltie so true what you say. I you just going to put them in the drawer and see where things go ?
Was not called for, why the hell not if there were any concerns as there clearly were ?!!
It needs to move fast to 40p!! don’t care a jot about short term chances buying at 5p and selling at 7/8p. I care about the long term holders who as it stands have been f****ng cheated here
Mattered for little in the end I say it again for can you pass phase 3 trials if there’s a liver toxicity issue . 1/4.million pounds gone up in smoke for me
Yes he needs to lead ,interviews today giving a clear way forward to rectify this. Seriously what is the point of phase 3 trials if you pass them but you don’t
Ivy why didn’t we fail phase 3 trials with this issue? . The science was never right if this was always a hidden issue . GL needs to come out and lead today with a possible way forward
Can someone please try and explain how we passed phase 3 if there was liver toxicity concerns ?! Makes zero sense
How did we pass phase 3 trials if there was liver toxicity issues?